Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 12:51pm
BIOV BEARS GET IN LINE TIME TO EAT THOSE @25
That's right alll right alright...TIME TO EAT those @25...the rest of you bears get in line for a higher ROI!! truth
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 12:31pm
BIOV THAT SEDI FILING OCT 4~WANG~ WINK WINK lol
Date Issuer Insider Transaction Amount New Balance Recent filings Filed 2022-10-04 21:44 Tx
...more
Voyageur Secures First International Sales Contract worth US$1.9 Million
posted Jun 02, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur Pharmaceuticals initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal CT diagnostic examinations. Starting with its barium contrast media product line, Voyageur’s strategy is to systematically introduce a comprehensive suite of imaging products, set to diversify the medical imaging landscape in the Canadian and international markets. ...read more
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 12:10pm
BIOV HAS THE "CE" MARK VALID FOR THE ENTIRE EU
Papilocare® has a CE mark valid for the entire EU and is currently marketed as a Class IIa medical device in Spain, France, Portugal, Italy, Belgium,
...more
(83)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on Oct 06, 2022 12:05pm
RE:WOW BIOV IS FIRING ON SO MANY CYLINDERS.. LOTS OF GOOD NEWS
so dec 2022 is the date we need to watch closely if they sign it , it means everything in place to lucnh and put products o nshelf very soon after.. it would be amanzing if we start 2023 with a bang
...more
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 12:05pm
BIOV~I AGREE HOOGIE6
@SINATH 0 21 minutes ago @Repal1960 If he could smash the 0.26¢ solid we would be entitled to a run in the 0.30
...more
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 11:43am
BIOV WHEN WE GET NEWS`PRODUCT IS ON SHELF~WHAT WILL SP BE?
Hmmmmmmmmmmmmmmmmm$$$$$$$$$$$$$$ cervical cancer milestone discovery omg!!!
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 11:39am
BIOV 1.2 MILLION INCOMING! A FINE TUNED ENGINE INDEED!
C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com 11:38:08 EDT Sym-X Bid - Ask Last Chg %Ch
...more
(83)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Oct 06, 2022 11:06am
WOW BIOV IS FIRING ON SO MANY CYLINDERS.. LOTS OF GOOD NEWS
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps by @newswire on 6 Oct 2022, 08:01
...more
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 10:27am
BIOV WILL WE BEAT YESTERDAY'S VOLUME 1.3? CURRENTLY 900K
C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com 10:26:34 EDT Sym-X Bid - Ask Last Chg %Ch Vol $Vol
...more
(54)
•••
bomdrou99
X
View Profile
View Bullboard History
Comment by
bomdrou99
on Oct 06, 2022 9:56am
RE:BIOV NICE NEWSWIRE$$ BEST PART "RAPID SALES & REVENUE"
Income guaranteed for 10 years.
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 9:30am
BIOV WHAT'S THE TASK TODAY?
A healthy breathing sp (shareprice) Breathe up & down & up & up & down. We want a stable sp trading HEALTHY...Simple dimple!! sheesh that was an AWESOME newswire. Hey like nobody
...more
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 06, 2022 9:22am
BIOV NICE NEWSWIRE$$ BEST PART "RAPID SALES & REVENUE"
Agreement Includes Right of First Refusal in the US for Ovosicare and Libicare VANCOUVER, BC, Oct. 6, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 06, 2022 8:02am
New Press Release - BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps
Agreement Includes Right of First Refusal in the US for Ovosicare and LibicareVANCOUVER, BC, Oct. 6, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that it has executed a binding Term Sheet ("Term Sheet" or "Agreement...
read article.
(372)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Oct 05, 2022 4:19pm
BIOV BROKERS & SHORTS KNEW~LOOK LOWEST SHORT POSITION EVER
short CHART.........DOES ANYBODY have October short position??? Can you please post see all companies Symbol Issue Name Shares Net Change Date
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday